PMID- 7941779 OWN - NLM STAT- MEDLINE DCOM- 19941110 LR - 20131121 IS - 1340-2544 (Print) IS - 1340-2544 (Linking) VI - 14 IP - 3 DP - 1994 Jun TI - Antitussive effect of (+/-) pentazocine in diabetic mice is mediated by delta-sites, but not by mu- or kappa-opioid receptors. PG - 147-52 AB - The effects of streptozotocin-induced diabetes on the antitussive effect of (+/-) pentazocine were examined in mice. Intracerebroventricular (i.c.v.) administration of (+/-) pentazocine produced a dose-dependent antitussive effect in both diabetic and non-diabetic mice. There were no significant differences in the antitussive effect of (+/-) pentazocine in diabetic and non-diabetic mice. The antitussive effect of i.c.v. (+/-) pentazocine was partially, but significantly, reduced in non-diabetic mice following pretreatment with either beta-funaltrexamine, a selective mu-opioid antagonist, or rimcazole, a specific sigma-site antagonist. The antitussive effect of (+/-) pentazocine in diabetic mice was significantly antagonized by pretreatment with rimcazole. However, beta-funaltrexamine had no effect on the antitussive effect of (+/-) pentazocine in diabetic mice. Furthermore, nor-binaltorphimine, a selective kappa-opioid receptor antagonist, had no significant effect on the antitussive effect of (+/-) pentazocine in either non-diabetic or diabetic mice. These results suggest that although the antitussive effect of i.c.v. (+/-) pentazocine in non-diabetic mice is mediated by both mu-opioid receptors and sigma-sites, in diabetic mice this effect is mainly mediated by sigma-sites. FAU - Kamei, J AU - Kamei J AD - Department of Pharmacology, Faculty of Pharmaceutical Sciences, Hoshi University, Tokyo, Japan. FAU - Iwamoto, Y AU - Iwamoto Y FAU - Misawa, M AU - Misawa M FAU - Nagase, H AU - Nagase H FAU - Kasuya, Y AU - Kasuya Y LA - eng PT - Journal Article PL - Japan TA - Nihon Shinkei Seishin Yakurigaku Zasshi JT - Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology JID - 9509023 RN - 0 (Antitussive Agents) RN - 0 (Receptors, Opioid, delta) RN - 0 (Receptors, Opioid, kappa) RN - 0 (Receptors, Opioid, mu) RN - 5W494URQ81 (Streptozocin) RN - RP4A60D26L (Pentazocine) SB - IM MH - Animals MH - Antitussive Agents/administration & dosage/*pharmacology MH - *Diabetes Mellitus, Experimental MH - Injections, Intraventricular MH - Mice MH - Mice, Inbred ICR MH - Pentazocine/administration & dosage/*pharmacology MH - Receptors, Opioid, delta/*agonists MH - Receptors, Opioid, kappa MH - Receptors, Opioid, mu MH - Streptozocin EDAT- 1994/06/01 00:00 MHDA- 1994/06/01 00:01 CRDT- 1994/06/01 00:00 PHST- 1994/06/01 00:00 [pubmed] PHST- 1994/06/01 00:01 [medline] PHST- 1994/06/01 00:00 [entrez] PST - ppublish SO - Nihon Shinkei Seishin Yakurigaku Zasshi. 1994 Jun;14(3):147-52.